The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,588.00
Ask: 12,590.00
Change: -34.00 (-0.27%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: HL pays special dividend after "extraordinary" year

Mon, 09th Aug 2021 08:26

(Alliance News) - Hargreaves Lansdown said Monday it delivered a record performance and exceptional growth during an "extraordinary and challenging year", as the fund supermarket brought in a record 233,000 net new clients in the year.

However, HL warned of higher costs in the year ahead amid new investments. The shares were down 9.6% early Monday in London, the worst FTSE 100 performer.

During the recent 12 months, Hargreaves said it benefited from market volatility that has been the "inevitable outcome" of a challenging year.

"Investor confidence started the year at a low but swung dramatically on the positive news of Covid vaccines and the political certainty provided by the US election and Brexit," said Chief Executive Officer Chris Hill.

For the financial year that ended June 30, revenue rose 15% to GBP631.0 million from GBP550.9 million last year, but pretax profit was GBP366.0 million, down 3.0% from GBP378.3 million.

The Bristol-based wealth management platform reported strong growth in assets under administration, which were up 30% to GBP135.5 billion from GBP104.0 billion. Net new business inflows were up 13% to GBP8.7 billion from GBP7.7 billion.

Hargreaves Lansdown declared a total dividend of 50.5 pence per share, down from 54.9p paid out in financial 2020. It also declared a special dividend of 12.0p.

The company said it is seeing a change in the demographic mix of its clients, with 83% of new clients under the age of 55. Further, it said it saw high levels of engagement from the "trading phenomenon around GameStop and so-called meme stocks".

Looking ahead, CEO Hill said: "With this continued investment in our people, proposition, service and technology as well as the cost of servicing an enlarged and growing client base, we expect 2022 costs to reflect this investment and continue to be broadly aligned to client growth.

"The impact of Covid on individuals, businesses and the economy still provides an uncertain backdrop to the current year. As we have eased out of lockdown and entered the summer months, we have seen a slowdown in dealing volumes and client activity versus the elevated levels this time last year, which is also normal for this time of year and in line with management expectations. However, given our enlarged client base, we would still expect to see stronger client activity in 2022 versus 2020 (which also included a few months of elevated activity during the peak of the pandemic period) and the breadth of proposition and client focus gives us confidence that as the year progresses, we will continue to win in this growing market."

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: down 0.2% at 7,106.90

----------

Hang Seng: up 0.4% at 26,290.24

Nikkei 225: Tokyo market closed for holiday.

DJIA: closed up 144.26 points, or 0.4%, at 35,208.51

S&P 500: closed up 7.42 points, or 0.2%, at 4,436.52

Nasdaq Composite: closed down 59.35 points, or 0.4%, at 14,835.76

----------

EUR: firm at USD1.1766 (USD1.1760)

GBP: up at USD1.3885 (USD1.3862)

USD: down at JPY110.12 (JPY110.30)

GOLD: down at USD1,746.42 per ounce (USD1,764.55)

OIL (Brent): down at USD69.04 a barrel (USD70.92)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Monday's Key Economic Events still to come

Japan Mountain Day holiday observed. Financial markets closed.

1100 BST Ireland industrial production

1000 EDT US employment trends index

1000 EDT US job openings

----------

A big investment plan aimed at modernizing America's infrastructure overcame a key legislative hurdle in the US Senate on Sunday, with legislation described as "historic" by President Joe Biden now almost certain to become law. The bill, months in the making, calls for USD550 billion in new federal spending on the nation's ageing infrastructure, including funds to slow the effects of climate change. The total USD1.2 trillion price tag includes some funds previously approved but not yet spent. Sunday evening saw the bill largely overcome several procedural votes in the Senate, with the slim Democratic majority bolstered by support from over a third of Republicans. It now goes to a final vote, with lawmakers primed to approve it as early as Monday if an agreement can be reached. But while there is now little doubt that the Senate will approve the almost 2,700-page text, its future is less certain in the House of Representatives, where left-wing and centrist factions have clashed over the size of the spending.

----------

BROKER RATING CHANGES

----------

MORGAN STANLEY REINITIATES ASTRAZENECA WITH 'OVERWEIGHT' - PRICE TARGET 9,800 PENCE

----------

RBC CUTS CONVATEC TO 'UNDERPERFORM' ('SECTOR PERFORM') - TARGET 213 (230) PENCE

----------

Liberum starts coverage on Made.com with Buy rating, 250p price target

----------

COMPANIES - FTSE 100

----------

Halma said it has completed three acquisitions for a total of GBP48.8 million and sold electronic security systems provider Texecom for GBP65 million. In the Safety sector, Halma acquired the Ramtech Group for GBP15.5 million in cash. In the Environmental & Analysis sector, Halma's pipeline inspection systems business, Mini-Cam, acquired Dancutter, a Danish designer and manufacturer of trenchless pipeline rehabilitation equipment for EUR18 million. Halma also bought Sensitron, a gas detection company based in Milan, Italy, for EUR21 million in cash. CEO

----------

BT Group is set to poach ASOS Chair Adam Crozier to be its own chair, the Sunday Times reported over the weekend. According to the newspaper, Crozier will resign from the online fashion retailer to focus on the telecoms firm, although he will stay on as chair of Whitbread and private data analytics business Kantar. Crozier beat three other candidates for the BT role, the newspaper reported, without saying where it got the information from. The 57-year-old was formerly chief executive of Royal Mail, ITV and the Football Association. At BT, he will be expected to stabilise the board after the resignation of previous chair Jan du Plessis, whose relationship with Chief Executive Philip Jansen broke down.

----------

COMPANIES - FTSE 250

----------

Philip Morris International raised its bid for asthma treatment firm Vectura to 165 pence per share, besting the 155p offer from private equity firm Carlyle to which Vectura had agreed on Friday. The new offer values Vectura at GBP1.02 billion. PMI previously had offered 150p per Vectura share.

----------

Shipping services firm Clarkson reported a robust set of interim earnings with strong trading across all areas of the business. For the six months to June 30, revenue was GBP190.1 million, up 5.4%, GBP180.4 million last year, and pretax profit rose 31% to GBP27.3 million from GBP20.9 million. The company declared an interim dividend of 27p, up 8% from 25p paid out at the halfway stage last year. CEO Andi Case said: "The company generated significantly increased profits in the first half of the year, aided by a robust performance in our Broking division and a strong recovery from our Financial division. I am also excited by the progress and momentum that our Sea/ platform is building. "We are confident in the outlook for Clarksons, which is well placed to capitalise on an improving demand-supply dynamic within shipping, offshore and renewables and from the wider global economic recovery."

----------

COMPANIES - MAIN MARKET AND AIM

----------

Germany's Delivery Hero has built a 5.1% stake in UK rival Deliveroo, crossing the 5% threshold on Friday, according to a regulatory release on Monday.

----------

Virgin Atlantic Airways is planning to list on the London Stock Exchange to take advantage of investors expectations of a quick economic recovery in international travel, the Financial Times reported on Sunday. The Crawley, West Sussex-based long-haul carrier has been talking to fund managers about a listing as early as this autumn, the newspaper reported, citing "a person familiar with the matter". The initial public offering will be led by bankers from Citigroup and Barclays, the FT said, noting this was first reported by Sky News. Virgin boss Richard Branson would likely lose his majority stake, it noted.

----------

COMPANIES - GLOBAL

----------

China Telecom could raise more than USD8 billion in a Shanghai initial public offering that would be the biggest this year, months after it was delisted in the US amid Washington's stand-off with Beijing. The firm said it had priced its offer at 4.53 yuan per share, which would be worth CNY47.1 billion, about USD7.3 billion, according to a filing with the Shanghai Stock Exchange on Friday. However, if an over-allotment option was exercised that would jump to CNY54 billion, or USD8.4 billion, Bloomberg News said. China Telecom was delisted by the New York Stock Exchange in January along with fellow state-owned telecoms firms China Mobile and China Unicom following an executive order by former president Donald Trump.

----------

Monday's Shareholder Meetings

NextEnergy Solar Fund Ltd - AGM

Shefa Gems Ltd - GM re mining unit sale and share consolidation

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.